Related Experiment Video
Updated: Apr 21, 2026
06:47
Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
Published on: September 27, 2017
10.3K
Pediatric exposure to laundry detergent pods.
Amanda L Valdez1, Marcel J Casavant2, Henry A Spiller2
1Center for Injury Research and Policy at Nationwide Children's Hospital, Columbus, Ohio; University of Washington School of Medicine, Seattle, Washington;
Pediatrics
|November 12, 2014
Summary
Laundry detergent pods pose a serious poisoning risk to young children. Increased prevention efforts, including safer packaging and public education, are crucial to reduce these exposures.
Area of Science:
- Toxicology
- Pediatric Emergency Medicine
- Public Health
Background:
- Laundry detergent pods represent a novel consumer product in the United States.
- Emerging data suggests potential risks associated with these products, particularly for vulnerable populations.
Purpose of the Study:
- To investigate the epidemiologic characteristics of laundry detergent pod exposures in young children.
- To analyze the clinical outcomes and severity of these exposures.
Main Methods:
- Utilized data from the National Poison Data System (NPDS).
- Analyzed cases of laundry detergent pod exposures among children under 6 years of age from 2012 to 2013.
Main Results:
- Over 17,000 exposures were recorded in children under 6 years old.
- Ingestion was the primary route of exposure (79.7%), with a significant increase in cases observed.
- Hospitalization occurred in 4.4% of cases, with serious medical outcomes reported in 7.5%.
Conclusions:
- Laundry detergent pods present a significant poisoning hazard to young children.
- Enhanced product safety measures, including packaging, labeling, and public awareness campaigns, are essential.
- Product reformulation may also reduce the severity of poisoning outcomes.
More Related Videos
Related Concept Videos
01:29Drug Dosing: Infants and Children
944
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
944
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
393
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
393
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
518
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
518
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
895
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
895
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
373
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
373
01:26Pharmaceutical Poisoning: Potential Scenarios
104
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
104